Promethazine-induced delirium with perceptual abnormalities: are we thinking broadly when assessing patients?

There is limited information about promethazine-induced delirium with psychotic symptoms. The aim is to highlight the importance of taking a detailed history including medication use/abuse of both prescribed, illicit and over-the-counter preparations. This paper describes a patient who presented with delirium in the context of overuse of promethazine (Phenergan) which was initially missed. The patient was treated successfully, following the diagnosis of promethazine-induced delirium. Clinicians should be aware of assessing patients presenting with delirium to explore the possibility of over-the-counter medication misuse.

[1]  F. Schifano,et al.  Beyond the ‘purple drank’: Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports , 2021, Journal of psychopharmacology.

[2]  J. Höjer,et al.  [Promethazine - an old pharmaceutical that has got a renaissance. An avalanche-like increase in the number of overdose cases in Sweden]. , 2018, Lakartidningen.

[3]  G. Benoist,et al.  [Purple drank: A dangerous cocktail]. , 2016, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[4]  B. Anderson,et al.  Abuse and Intentional Misuse of Promethazine Reported to US Poison Centers: 2002 to 2012 , 2015, Journal of addiction medicine.

[5]  G. Paolino,et al.  Topical Promethazine Side Effects: Our Experience and Review of the Literature , 2013, BioMed research international.

[6]  G. Isbister,et al.  Promethazine overdose: clinical effects, predicting delirium and the effect of charcoal. , 2008, QJM : monthly journal of the Association of Physicians.

[7]  G. Keane,et al.  Prolonged Anticholinergic Delirium Following Antihistamine Overdose , 2007, Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists.

[8]  O. Gleason,et al.  Promethazine-induced psychosis in a 16-year-old girl. , 2004, Psychosomatics.

[9]  K. Chan-Tack,et al.  Neuroleptic malignant syndrome due to promethazine. , 1999, Southern medical journal.